CBX8 and hepatocellular carcinoma: Clinical data of a cohort containing 369 HCC cases and 50 non-tumor cases were obtained from TCGA website (https://www.cancer.gov), and analysis revealed that CBX8 was upregulated in HCC lesions when compared with normal tissues (Figure 8A).